Identification of an HLA-A3-restricted Cytotoxic T Lymphocyte (CTL) epitope from ML-IAP [6]

Journal of Investigative Dermatology

Volumn 122, Issue 5, 2004, Pages 1336-1337

  Andersen, Mads Hald ^a,b   Becker, Jürgen C ^a,b   Thor Straten, Per ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A3 ANTIGEN; PROTEIN; PROTEIN ML IAP; UNCLASSIFIED DRUG;

CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN CELL; LETTER; MELANOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 2442471613     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22508.x     Document Type: Letter

References (10)

1. Andersen MH, Reker S, Becker JC, thor Straten P: The melanoma inhibitor of apoptosis protein ML-IAP: A target for spontaneous cytotoxic T-cell responses. J Invest Dermatol 122:392-399, 2004
2. Campoli M, Chang CC, Ferrone S: HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 19 (Suppl.) 4:A40-5.:A40-A45, 2002
3. Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL: Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18:89-95, 1997
4. Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276:3238-3246, 2001
5. Kessler JH, Mommaas B, Mutis T, et al: Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum Immunol 64:245-255, 2003
6. Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ: Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 20:961-976, 2000
7. Kubo RT, Sette A, Grey HM, et al: Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152:3913-3924, 1994
8. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S: Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Adv Immunol 74:181-273, 2000
9. Nachmias B, Ashhab Y, Bucholtz V, et al: Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: Implications for drug-resistant melanoma. Cancer Res 63:6340-6349, 2003
10. Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM: Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res 7:3343-3348, 2001